| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.941 | 0.002 | 0.941 | Alpha adrenoreceptor antagonist | 0.941 0.002 DBMET02603 0.941 0.002 DBMET02604 | ||
| 0.913 | 0.002 | 0.913 | Alpha 1 adrenoreceptor antagonist | 0.913 0.002 DBMET02603 0.913 0.002 DBMET02604 | ||
| 0.898 | 0.002 | 0.898 | Alpha 2a adrenoreceptor antagonist | 0.898 0.002 DBMET02603 0.898 0.002 DBMET02604 | ||
| 0.895 | 0.002 | 0.895 | Alpha 1a adrenoreceptor antagonist | 0.895 0.002 DBMET02603 0.895 0.002 DBMET02604 | ||
| 0.876 | 0.002 | 0.876 | Alpha 2c adrenoreceptor antagonist | 0.876 0.002 DBMET02603 0.876 0.002 DBMET02604 | ||
| 0.861 | 0.003 | 0.861 | Alpha 2 adrenoreceptor antagonist | 0.861 0.003 DBMET02603 0.861 0.003 DBMET02604 | ||
| 0.713 | 0.004 | 0.713 | Antiadrenergic | 0.713 0.004 DBMET02603 0.713 0.004 DBMET02604 | ||
| 0.712 | 0.004 | 0.712 | Adrenaline antagonist | 0.712 0.004 DBMET02603 0.712 0.004 DBMET02604 | ||
| 0.684 | 0.003 | 0.684 | Alpha 1d adrenoreceptor antagonist | 0.684 0.003 DBMET02603 0.684 0.003 DBMET02604 | ||
| 0.678 | 0.003 | 0.678 | Alpha 1b adrenoreceptor antagonist | 0.678 0.003 DBMET02603 0.678 0.003 DBMET02604 | ||
| 0.641 | 0.003 | 0.641 | Alpha 1 adrenoreceptor agonist | 0.641 0.003 DBMET02603 0.641 0.003 DBMET02604 | ||
| 0.631 | 0.003 | 0.631 | Alpha 2b adrenoreceptor antagonist | 0.631 0.003 DBMET02603 0.631 0.003 DBMET02604 | ||
| 0.516 | 0.005 | 0.516 | DNA methylase inhibitor | 0.516 0.005 DBMET02603 0.516 0.005 DBMET02604 | ||
| 0.441 | 0.004 | 0.441 | Alpha adrenoreceptor agonist | 0.441 0.004 DBMET02603 0.441 0.004 DBMET02604 | ||
| 0.339 | 0.028 | 0.339 | Cyclic AMP phosphodiesterase inhibitor | 0.339 0.028 DBMET02603 0.339 0.028 DBMET02604 | ||
| 0.407 | 0.107 | 0.407 | Caspase 9 stimulant | 0.407 0.107 DBMET02603 0.407 0.107 DBMET02604 | ||
| 0.33 | 0.052 | 0.33 | Hypoxia-inducible factor 1 alpha inhibitor | 0.33 0.052 DBMET02603 0.33 0.052 DBMET02604 | ||
| 0.382 | 0.117 | 0.382 | MAP kinase 1 inhibitor | 0.382 0.117 DBMET02603 0.382 0.117 DBMET02604 | ||
| 0.283 | 0.033 | 0.283 | DNA methyltransferase I inhibitor | 0.283 0.033 DBMET02603 0.283 0.033 DBMET02604 | ||
| 0.315 | 0.076 | 0.315 | Vasodilator, coronary | 0.315 0.076 DBMET02603 0.315 0.076 DBMET02604 | ||
| 0.257 | 0.025 | 0.257 | Protein kinase stimulant | 0.257 0.025 DBMET02603 0.257 0.025 DBMET02604 | ||
| 0.3 | 0.079 | 0.3 | Caspase 3 stimulant | 0.3 0.079 DBMET02603 0.3 0.079 DBMET02604 | ||
| 0.196 | 0.004 | 0.196 | Alpha 2 adrenoreceptor agonist | 0.196 0.004 DBMET02603 0.196 0.004 DBMET02604 | ||
| 0.203 | 0.014 | 0.203 | 5 Hydroxytryptamine 1A antagonist | 0.203 0.014 DBMET02603 0.203 0.014 DBMET02604 | ||
| 0.232 | 0.051 | 0.232 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.232 0.051 DBMET02603 0.232 0.051 DBMET02604 | ||
| 0.195 | 0.015 | 0.195 | EphA2 antagonist | 0.195 0.015 DBMET02603 0.195 0.015 DBMET02604 | ||
| 0.234 | 0.061 | 0.234 | ErbB-1 antagonist | 0.234 0.061 DBMET02603 0.234 0.061 DBMET02604 | ||
| 0.271 | 0.107 | 0.271 | Apoptosis antagonist | 0.271 0.107 DBMET02603 0.271 0.107 DBMET02604 | ||
| 0.167 | 0.018 | 0.167 | 5 Hydroxytryptamine agonist | 0.167 0.018 DBMET02603 0.167 0.018 DBMET02604 | ||
| 0.23 | 0.082 | 0.23 | Vasodilator | 0.23 0.082 DBMET02603 0.23 0.082 DBMET02604 | ||
| 0.168 | 0.02 | 0.168 | 5 Hydroxytryptamine 1 antagonist | 0.168 0.02 DBMET02603 0.168 0.02 DBMET02604 | ||
| 0.22 | 0.074 | 0.22 | EphB2 antagonist | 0.22 0.074 DBMET02603 0.22 0.074 DBMET02604 | ||
| 0.135 | 0.012 | 0.135 | mTOR complex 2 inhibitor | 0.135 0.012 DBMET02603 0.135 0.012 DBMET02604 | ||
| 0.157 | 0.044 | 0.157 | Epidermal growth factor receptor kinase inhibitor | 0.157 0.044 DBMET02603 0.157 0.044 DBMET02604 | ||
| 0.15 | 0.037 | 0.15 | Ephrin antagonist | 0.15 0.037 DBMET02603 0.15 0.037 DBMET02604 | ||
| 0.155 | 0.042 | 0.155 | 5 Hydroxytryptamine 2 antagonist | 0.155 0.042 DBMET02603 0.155 0.042 DBMET02604 | ||
| 0.161 | 0.056 | 0.161 | RET inhibitor | 0.161 0.056 DBMET02603 0.161 0.056 DBMET02604 | ||
| 0.24 | 0.135 | 0.24 | Vasodilator, peripheral | 0.24 0.135 DBMET02603 0.24 0.135 DBMET02604 | ||
| 0.153 | 0.048 | 0.153 | 5 Hydroxytryptamine antagonist | 0.153 0.048 DBMET02603 0.153 0.048 DBMET02604 | ||
| 0.159 | 0.06 | 0.159 | Activin receptor-like kinase 2 inhibitor | 0.159 0.06 DBMET02603 0.159 0.06 DBMET02604 | ||
| 0.143 | 0.045 | 0.143 | Interleukin 1b antagonist | 0.143 0.045 DBMET02603 0.143 0.045 DBMET02604 | ||
| 0.123 | 0.025 | 0.123 | mTOR complex 1 inhibitor | 0.123 0.025 DBMET02603 0.123 0.025 DBMET02604 | ||
| 0.105 | 0.015 | 0.105 | 5 Hydroxytryptamine 1A agonist | 0.105 0.015 DBMET02603 0.105 0.015 DBMET02604 | ||
| 0.172 | 0.088 | 0.172 | P-glycoprotein inhibitor | 0.172 0.088 DBMET02603 0.172 0.088 DBMET02604 | ||
| 0.169 | 0.088 | 0.169 | MAP kinase kinase 5 inhibitor | 0.169 0.088 DBMET02603 0.169 0.088 DBMET02604 | ||
| 0.083 | 0.007 | 0.083 | Alpha 1L adrenoreceptor antagonist | 0.083 0.007 DBMET02603 0.083 0.007 DBMET02604 | ||
| 0.108 | 0.033 | 0.108 | Glutamate release inhibitor | 0.108 0.033 DBMET02603 0.108 0.033 DBMET02604 | ||
| 0.141 | 0.069 | 0.141 | Toll-Like receptor 9 antagonist | 0.141 0.069 DBMET02603 0.141 0.069 DBMET02604 | ||
| 0.135 | 0.064 | 0.135 | c-Src kinase inhibitor | 0.135 0.064 DBMET02603 0.135 0.064 DBMET02604 | ||
| 0.212 | 0.144 | 0.212 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.212 0.144 DBMET02603 0.212 0.144 DBMET02604 | ||
| 0.121 | 0.055 | 0.121 | Polo-like kinase-4 inhibitor | 0.121 0.055 DBMET02603 0.121 0.055 DBMET02604 | ||
| 0.149 | 0.084 | 0.149 | Src kinase inhibitor | 0.149 0.084 DBMET02603 0.149 0.084 DBMET02604 | ||
| 0.101 | 0.036 | 0.101 | Adrenaline agonist | 0.101 0.036 DBMET02603 0.101 0.036 DBMET02604 | ||
| 0.099 | 0.042 | 0.099 | ErbB-3 antagonist | 0.099 0.042 DBMET02603 0.099 0.042 DBMET02604 | ||
| 0.121 | 0.071 | 0.121 | TRKB antagonist | 0.121 0.071 DBMET02603 0.121 0.071 DBMET02604 | ||
| 0.085 | 0.036 | 0.085 | Phosphodiesterase V inhibitor | 0.085 0.036 DBMET02603 0.085 0.036 DBMET02604 | ||
| 0.083 | 0.037 | 0.083 | Phosphodiesterase 5A inhibitor | 0.083 0.037 DBMET02603 0.083 0.037 DBMET02604 | ||
| 0.082 | 0.037 | 0.082 | MAP kinase 7 inhibitor | 0.082 0.037 DBMET02603 0.082 0.037 DBMET02604 | ||
| 0.092 | 0.051 | 0.092 | Epidermal growth factor antagonist | 0.092 0.051 DBMET02603 0.092 0.051 DBMET02604 | ||
| 0.07 | 0.029 | 0.07 | EphB4 antagonist | 0.07 0.029 DBMET02603 0.07 0.029 DBMET02604 | ||
| 0.071 | 0.033 | 0.071 | Phosphatidylinositol kinase inhibitor | 0.071 0.033 DBMET02603 0.071 0.033 DBMET02604 | ||
| 0.083 | 0.05 | 0.083 | ErbB-4 antagonist | 0.083 0.05 DBMET02603 0.083 0.05 DBMET02604 | ||
| 0.053 | 0.033 | 0.053 | 5 Hydroxytryptamine 4 antagonist | 0.053 0.033 DBMET02603 0.053 0.033 DBMET02604 | ||
| 0.054 | 0.034 | 0.054 | 5 Hydroxytryptamine 2 agonist | 0.054 0.034 DBMET02603 0.054 0.034 DBMET02604 | ||
| 0.112 | 0.091 | 0.112 | DNA repair enzyme inhibitor | 0.112 0.091 DBMET02603 0.112 0.091 DBMET02604 | ||
| 0.045 | 0.025 | 0.045 | DNA-dependent protein kinase inhibitor | 0.045 0.025 DBMET02603 0.045 0.025 DBMET02604 | ||
| 0.104 | 0.084 | 0.104 | Beta amyloid protein antagonist | 0.104 0.084 DBMET02603 0.104 0.084 DBMET02604 | ||
| 0.099 | 0.081 | 0.099 | CDC-like kinase 3 inhibitor | 0.099 0.081 DBMET02603 0.099 0.081 DBMET02604 | ||
| 0.053 | 0.036 | 0.053 | 5 Hydroxytryptamine 1 agonist | 0.053 0.036 DBMET02603 0.053 0.036 DBMET02604 | ||
| 0.051 | 0.036 | 0.051 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.051 0.036 DBMET02603 0.051 0.036 DBMET02604 | ||
| 0.143 | 0.128 | 0.143 | Antimitotic | 0.143 0.128 DBMET02603 0.143 0.128 DBMET02604 | ||
| 0.247 | 0.232 | 0.247 | 5 Hydroxytryptamine release inhibitor | 0.247 0.232 DBMET02603 0.247 0.232 DBMET02604 | ||
| 0.069 | 0.056 | 0.069 | Phosphodiesterase VIII inhibitor | 0.069 0.056 DBMET02603 0.069 0.056 DBMET02604 | ||
| 0.096 | 0.083 | 0.096 | Mucolytic | 0.096 0.083 DBMET02603 0.096 0.083 DBMET02604 | ||
| 0.073 | 0.063 | 0.073 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.073 0.063 DBMET02603 0.073 0.063 DBMET02604 | ||
| 0.048 | 0.04 | 0.048 | Alpha 1b adrenoreceptor agonist | 0.048 0.04 DBMET02603 0.048 0.04 DBMET02604 | ||
| 0.146 | 0.138 | 0.146 | Focal adhesion kinase 2 inhibitor | 0.146 0.138 DBMET02603 0.146 0.138 DBMET02604 | ||
| 0.05 | 0.044 | 0.05 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.05 0.044 DBMET02603 0.05 0.044 DBMET02604 | ||
| 0.071 | 0.066 | 0.071 | 5 Hydroxytryptamine 2A antagonist | 0.071 0.066 DBMET02603 0.071 0.066 DBMET02604 | ||
| 0.018 | 0.013 | 0.018 | Complement factor D inhibitor | 0.018 0.013 DBMET02603 0.018 0.013 DBMET02604 | ||
| 0.097 | 0.093 | 0.097 | Activin receptor-like kinase 4 inhibitor | 0.097 0.093 DBMET02603 0.097 0.093 DBMET02604 | ||
| 0.094 | 0.091 | 0.094 | 5 Hydroxytryptamine 2B antagonist | 0.094 0.091 DBMET02603 0.094 0.091 DBMET02604 | ||
| 0.072 | 0.071 | 0.072 | ALK inhibitor | 0.072 0.071 DBMET02603 0.072 0.071 DBMET02604 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |